• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FIGO I-IIB期子宫颈腺癌的根治性子宫切除术。

Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix.

作者信息

Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S, Sasajima Y, Tsuda H

机构信息

Division of Gynecology, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Br J Cancer. 2009 May 5;100(9):1400-5. doi: 10.1038/sj.bjc.6605048.

DOI:10.1038/sj.bjc.6605048
PMID:19401699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2694432/
Abstract

A retrospective analysis was carried out to identify risk factors for survival and relapse in patients with FIGO stage I-IIB cervical adenocarcinoma (AC), who underwent radical hysterectomy, and to compare outcome and spread pattern with those of squamous cell carcinoma (SCC). One hundred and twenty-three FIGO stage I-IIB patients with AC and 455 patients with SCC, who all underwent primary radical hysterectomy, were reviewed. Among the patients with AC, Cox model identified tumour size (95% CI: 1.35-30.71) and node metastasis (95% CI: 5.09-53.44) as independent prognostic factors for survival, and infiltration to vagina (95% CI: 1.15-5.76) and node metastasis (95% CI: 6.39-58.87) as independent prognostic factors for relapse. No significant difference was found in survival or relapse between the AC and SCC groups, after adjusting for other clinicopathological characteristics using Cox model. No significant difference was found in the positive rates of lymph nodes or location of initial failure sites between the two groups, but ovarian metastatic rate was significantly higher in patients with pathologic stage IIB AC (P=0.02). Positive node is a common independent prognostic factor for survival and relapse of patients with AC. FIGO stage I-IIB patients with AC or SCC, who underwent radical hysterectomy, have similar prognosis and spread pattern, but different ovarian metastasis rates.

摘要

进行了一项回顾性分析,以确定国际妇产科联盟(FIGO)I-IIB期宫颈腺癌(AC)患者接受根治性子宫切除术后生存和复发的危险因素,并将其结果和扩散模式与鳞状细胞癌(SCC)患者进行比较。回顾了123例FIGO I-IIB期AC患者和455例SCC患者,所有患者均接受了初次根治性子宫切除术。在AC患者中,Cox模型确定肿瘤大小(95%CI:1.35-30.71)和淋巴结转移(95%CI:5.09-53.44)是生存的独立预后因素,阴道浸润(95%CI:1.15-5.76)和淋巴结转移(95%CI:6.39-58.87)是复发的独立预后因素。使用Cox模型调整其他临床病理特征后,AC组和SCC组在生存或复发方面未发现显著差异。两组之间淋巴结阳性率或初始失败部位位置无显著差异,但病理IIB期AC患者的卵巢转移率显著更高(P=0.02)。阳性淋巴结是AC患者生存和复发的常见独立预后因素。接受根治性子宫切除术的FIGO I-IIB期AC或SCC患者具有相似的预后和扩散模式,但卵巢转移率不同。

相似文献

1
Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix.FIGO I-IIB期子宫颈腺癌的根治性子宫切除术。
Br J Cancer. 2009 May 5;100(9):1400-5. doi: 10.1038/sj.bjc.6605048.
2
Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.FIGO IIB期宫颈癌根治性子宫切除术:临床病理特征及预后评估
Gynecol Oncol. 2009 Jul;114(1):69-74. doi: 10.1016/j.ygyno.2009.03.026. Epub 2009 Apr 26.
3
Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.比较 FIGO 分期 I 期至 II 期宫颈腺鳞癌和腺癌患者接受根治性子宫切除术的预后。
Int J Gynecol Cancer. 2012 Oct;22(8):1389-97. doi: 10.1097/IGC.0b013e31826b5d9b.
4
Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery.比较 FIGO 分期 IB-IIA 期宫颈癌根治术后中国患者腺癌和腺鳞癌的预后。
BMC Cancer. 2020 Jul 16;20(1):664. doi: 10.1186/s12885-020-07148-x.
5
Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).比较接受手术切除后放疗的宫颈癌患者中腺癌和腺鳞癌的临床结局:一项多中心回顾性研究(KROG 13-10)。
Gynecol Oncol. 2014 Mar;132(3):618-23. doi: 10.1016/j.ygyno.2014.01.043. Epub 2014 Jan 31.
6
Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.根治性子宫切除术及辅助放疗或放化疗治疗宫颈腺癌或腺鳞癌的临床行为和结局。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):420-7. doi: 10.1016/j.ijrobp.2011.12.013. Epub 2012 Feb 24.
7
Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.组织学亚型对手术治疗的 IA2-IIB 期宫颈癌患者生存的影响:腺癌与鳞癌。
Gynecol Oncol. 2012 Oct;127(1):114-20. doi: 10.1016/j.ygyno.2012.06.021. Epub 2012 Jun 21.
8
Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.根治性子宫切除术和盆腔淋巴结切除术治疗 IB-IIB 期宫颈腺癌患者的预后因素。
J Surg Oncol. 2010 Apr 1;101(5):413-7. doi: 10.1002/jso.21499.
9
Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study.早期淋巴结阴性宫颈腺癌和鳞状细胞癌在子宫切除术后显示出相似的生存结果:一项基于人群的研究。
J Gynecol Oncol. 2017 Nov;28(6):e81. doi: 10.3802/jgo.2017.28.e81.
10
Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.伴有盆腔淋巴结转移的子宫颈Ib1期腺鳞癌患者预后较差。
Kobe J Med Sci. 2006;52(1-2):9-15.

引用本文的文献

1
Associations between genetic HPV 16 diversity and cervical cancer prognosis.人乳头瘤病毒16型(HPV 16)基因多样性与宫颈癌预后之间的关联。
PLoS One. 2025 Jun 25;20(6):e0308895. doi: 10.1371/journal.pone.0308895. eCollection 2025.
2
Comparison of oncological outcomes and complication rate between radical hysterectomy and concurrent chemoradiotherapy in stage IIICr cervical cancer without parametrial invasion.IIICr期无宫旁浸润宫颈癌根治性子宫切除术与同步放化疗的肿瘤学结局及并发症发生率比较
BMC Cancer. 2025 Apr 30;25(1):811. doi: 10.1186/s12885-025-14196-8.
3
Predictive Role of Preoperative Whole-Body 18F-FDG PET/CT for Risk Stratification of Early-Stage (FIGO I-IIA) Cervical Cancer Patients Treated by Surgery.术前全身18F-FDG PET/CT对手术治疗的早期(国际妇产科联盟I-IIA期)宫颈癌患者风险分层的预测作用
Cureus. 2024 Jan 28;16(1):e53107. doi: 10.7759/cureus.53107. eCollection 2024 Jan.
4
Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.基于组织学类型的 2018 年 FIGO 分期 IIIC 期宫颈癌的初始治疗:一项 14 年多中心研究。
Cancer Med. 2023 Oct;12(19):19617-19632. doi: 10.1002/cam4.6586. Epub 2023 Sep 28.
5
Clear cell carcinoma of the uterine cervix; an unusual HPV-independent tumor: Clinicopathological features, PD-L1 expression, and mismatch repair protein deficiency status of 16 cases.子宫颈透明细胞癌;一种不常见的非HPV相关肿瘤:16例病例的临床病理特征、PD-L1表达及错配修复蛋白缺陷状态
Turk J Obstet Gynecol. 2023 Sep 4;20(3):164-173. doi: 10.4274/tjod.galenos.2023.62819.
6
Impact of different post-operative treatment modalities on long-term outcomes in International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIICp cervical cancer.不同术后治疗方式对国际妇产科联盟(FIGO)2018 期 IIICp 宫颈癌患者长期结局的影响。
Int J Gynecol Cancer. 2023 Jun 5;33(6):882-889. doi: 10.1136/ijgc-2022-004234.
7
Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy.根据手术和放疗治疗的宫颈内膜腺癌患者的更新 WHO 分类预测预后。
J Gynecol Oncol. 2022 Nov;33(6):e71. doi: 10.3802/jgo.2022.33.e71. Epub 2022 Aug 9.
8
Factors Associated with Patient Survival in Clear Cell Adenocarcinoma of the Cervix: A Single-Center Experience in China.宫颈透明细胞腺癌患者生存的相关因素:中国单中心经验
Int J Gen Med. 2022 May 3;15:4625-4634. doi: 10.2147/IJGM.S358094. eCollection 2022.
9
The best postoperative adjuvant therapy for patients with early stage cervical adenosquamous carcinoma.早期宫颈腺鳞癌患者的最佳术后辅助治疗。
BMC Womens Health. 2022 Apr 12;22(1):112. doi: 10.1186/s12905-021-01588-8.
10
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy.子宫颈癌的诊断、治疗与随访。德国妇科与产科学会(DGGG)、德国妇科肿瘤学会(DKG)和德国妇科与产科学会健康保险分会(DKH)指南(S3级,德国医学科学院质量与效率医学研究所登记号:032/033OL,2021年5月)——第1部分:关于流行病学、筛查、诊断与治疗的建议
Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):139-180. doi: 10.1055/a-1671-2158. eCollection 2022 Feb.

本文引用的文献

1
Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.子宫颈早期腺癌与鳞状细胞癌生物学行为的比较。
Eur J Obstet Gynecol Reprod Biol. 2008 Feb;136(2):215-23. doi: 10.1016/j.ejogrb.2006.10.021. Epub 2006 Nov 27.
2
What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study.子宫颈鳞状细胞癌和腺癌之间的差异是什么?一项配对病例对照研究。
Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1569-73. doi: 10.1111/j.1525-1438.2006.00628.x.
3
Radical hysterectomy for stage IIB cervical cancer: a review.IIB期宫颈癌根治性子宫切除术:综述
Int J Gynecol Cancer. 2005 Nov-Dec;15(6):995-1001. doi: 10.1111/j.1525-1438.2005.00259.x.
4
Carcinoma of the cervix uteri.子宫颈癌
Int J Gynaecol Obstet. 2003 Oct;83 Suppl 1:41-78. doi: 10.1016/s0020-7292(03)90115-9.
5
Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma.腺鳞组织学预示低风险IB1期宫颈腺癌预后不良。
Gynecol Oncol. 2003 Dec;91(3):558-62. doi: 10.1016/j.ygyno.2003.08.020.
6
Does histology influence prognosis in patients with early-stage cervical carcinoma?组织学对早期宫颈癌患者的预后有影响吗?
Cancer. 2001 Dec 15;92(12):2999-3004. doi: 10.1002/1097-0142(20011215)92:12<2999::aid-cncr10145>3.0.co;2-1.
7
Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix.组织学亚型对子宫颈腺癌患者的总生存期影响较小:一项基于人群的505例宫颈非鳞状细胞癌患者预后因素研究。
Cancer. 2001 Nov 1;92(9):2471-83. doi: 10.1002/1097-0142(20011101)92:9<2471::aid-cncr1597>3.0.co;2-k.
8
A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix.子宫颈鳞状细胞癌与腺癌卵巢转移情况的比较。
Gynecol Oncol. 2001 Sep;82(3):504-9. doi: 10.1006/gyno.2001.6316.
9
A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.子宫颈病理I b期腺癌与鳞状细胞癌预后的比较。
Gynecol Oncol. 2000 Nov;79(2):289-93. doi: 10.1006/gyno.2000.5935.
10
Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.接受根治性子宫切除术后的子宫颈Ib-IIb期腺癌患者的预后及临床病理特征
Eur J Surg Oncol. 2000 Aug;26(5):464-7. doi: 10.1053/ejso.1999.0923.